Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Learn how Volatility Dividend Aristocrats Etf behaves across cycles and what it means for risk budgeting and position sizing in volatile markets.
20,128 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
IBM shares surged as a resurfaced media clip spotlighted the company’s leadership while federal backing for quantum r...
Micron shares fell about 7% in mid-morning trading as Broadcom issued a softer AI chip outlook, triggering a broad se...
Ad-tech leaders Trade Desk and AppLovin face renewed scrutiny in 2026 as AI investments pressure margins and trigger ...
Blockchain investigator ZachXBT raises red flags about Rain Protocol, citing on-chain patterns and a lofty market cap...
A one-time SSA option lets retirees undo a Social Security claim within 12 months, potentially lifting monthly checks...
The Federal Housing Administration announces the resignation of Commissioner Frank Cassidy, effective June 1, ending ...
Nebius has sprinted ahead in 2026, climbing 170% as AI infrastructure accelerates. This article breaks down the drive...
A Honeywell-backed trapped-ion quantum company began trading on NASDAQ, priced around $60 a share and signaling that ...
A new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
Galaxy Digital lowers its odds on the CLARITY Act, putting clarity chances passage this year at 60% as lawmakers rush...
An indie comedy topped the weekend box office, outpacing a big-budget action film and highlighting how households are...